Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Jeff Harrell Podcasts

show episodes
 
Artwork
 
Hosted by Jeff Harrell and dropping every other Monday, Discovering McKinney dives into the amazing stories that make McKinney, Texas so great. We’ll search for the best McKinney burger, investigate stories of ghosts and outlaws, look into the live McKinney music scene, uncover hidden gems throughout the city, and much, much more. But mostly we’ll tell the stories of the extraordinary ordinary people behind this great town.
  continue reading
 
When it comes to navigating the twists and turns of stock market investing, do you choose poorly? Or wisely? Experience suggests most of us are bad investors, although you may not hear this from speaking with friends and family. Sadly, the compounding effect of poor investment decisions can add up to a lot of money lost and time wasted. On “Invested Poorly: Sad Tales of FInancial Fails,” host Jeff Harrell offers unique perspective and energy as he guides you through common pitfalls that trap ...
  continue reading
 
Artwork

1
Catalyst Pharmacy Podcast

RedSail Technologies

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
On the Catalyst podcast, we dive into current events that are shaping how pharmacists approach their patients and their business. Fuel your passion for pharmacy, one conversation at a time. Hosted by Mark Bivins, Chief Growth Officer, RedSail Technologies
  continue reading
 
A podcast on statistical science and clinical trials. Explore the intricacies of Bayesian statistics and adaptive clinical trials. Uncover methods that push beyond conventional paradigms, ushering in data-driven insights that enhance trial outcomes while ensuring safety and efficacy. Join us as we dive into complex medical challenges and regulatory landscapes, offering innovative solutions tailored for pharma pioneers. Featuring expertise from industry leaders, each episode is crafted to pro ...
  continue reading
 
Loading …
show series
 
In episode 37 of "In the Interim…", Dr. Jeff Saver, Director of the UCLA Comprehensive Stroke and Vascular Neurology Program, details his shift from behavioral neurology to clinical stroke research after early engagement with multicenter trials like TOAST. The discussion covers the biology of acute ischemic stroke, quantifying neuronal loss, and th…
  continue reading
 
In Episode 36 of "In the Interim…", Dr. Scott Berry and Dr. Don Berry analyze the Phase II trial of Lecanemab (BAN2401) in Alzheimer’s disease, focusing on the application of adaptive Bayesian methods following persistent failures in Alzheimer’s drug development. The conversation covers the specific design features of five active arms, response ada…
  continue reading
 
On this episode of “In the Interim…”, which is co-sponsored by the Journal of Statistics and Data Science Education, Dr. Scott Berry talks with Dr. Jim Albert, Professor Emeritus at Bowling Green State University, whose extensive work encompasses Bayesian statistics and computation, sports analytics, and decades of exemplary teaching. Dr. Albert sh…
  continue reading
 
In this episode of "In the Interim…", Dr. Scott Berry examines the concept of “digital twins” in clinical trials. He details how simulation of clinical trials is a direct analog of digital twin methodology, allowing for the in-silico modeling of the physical trial conduct, enrollment, dropouts, and patient outcomes under varied assumptions. Scott d…
  continue reading
 
Pharmacists have been vaccinating for years—it's about time they get the recognition (and reimbursement) they deserve. Marc Ost, Co-Owner of Eric’s RX Shoppe in Horsham, PA, is here to make it happen. Marc joins us to talk about how he’s driving change in vaccine access and reimbursement, from advocating with the FTC and state legislators to pionee…
  continue reading
 
In this episode of "In the Interim…", Dr. Scott Berry interviews Dr. Andrew Thomson, owner and lead consultant of Regnitio. Thomson discusses his academic progression from mathematics at Cambridge to a Master’s at Southampton and advanced study with Prof. Sylvia Richardson at Imperial College, followed by doctoral work in cluster randomized trials …
  continue reading
 
In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele analyze how regulatory, editorial, and science community standards often impose additional, inconsistent requirements for novel methods in clinical trial design, rarely applied to standard approaches. Examples from oncology, enrichment trials, platform studies, and endpoint an…
  continue reading
 
Join us for an exclusive conversation with NCPA President Jeff Harrell, where we talk about the future of pharmacy and the leadership that’s shaping it. Jeff shares how he and the NCPA team are working to reshape pharmacy education, advocate for fair reimbursement, and foster unity among owners everywhere. He also shares how he’s scaling his own bu…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play